Provided by Tiger Trade Technology Pte. Ltd.

AvePoint Inc.

10.20
+0.25002.51%
Volume:366.42K
Turnover:3.72M
Market Cap:2.20B
PE:-1.02K
High:10.33
Open:9.90
Low:9.86
Close:9.95
52wk High:20.25
52wk Low:9.86
Shares:215.79M
Float Shares:137.00M
Volume Ratio:0.79
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0100
EPS(LYR):-0.1600
ROE:0.67%
ROA:2.78%
PB:4.72
PE(LYR):-63.75

Loading ...

Earning Preview: AvePoint Inc. This quarter’s revenue is expected to increase by 26.02%, and institutional views are bullish

Earnings Agent
·
Feb 19

Analysts Offer Insights on Technology Companies: AvePoint (AVPT) and Advanced Micro Devices (AMD)

TIPRANKS
·
9 hours ago

AvePoint Is Maintained at Buy by DA Davidson

Dow Jones
·
Feb 20

AvePoint to Present at Morgan Stanley TMT Conference

Reuters
·
Feb 13

High Insider Ownership Fuels Growth Stocks In February 2026

Simply Wall St.
·
Feb 12

Assessing AvePoint (AVPT) Valuation After New Agentic AI Governance And Expanded Cloud Backup Tools

Simply Wall St.
·
Feb 09

AvePoint Unveils New Agentic AI Governance Features in Upcoming Innovates Webinar

Reuters
·
Feb 04

AvePoint to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26

GlobeNewswire
·
Feb 04

AvePoint Is Maintained at Buy by B. Riley Securities

Dow Jones
·
Feb 02

B. Riley Cuts Price Target on AvePoint to $22 From $25, Keeps Buy Rating

MT Newswires Live
·
Feb 02

Exploring High Growth Tech Stocks In The US Market

Simply Wall St.
·
Jan 26

AvePoint (NASDAQ:AVPT) Is Looking To Continue Growing Its Returns On Capital

Simply Wall St.
·
Jan 16

AvePoint Executive Chairman Xunkai Gong Reports Sale of Common Shares

Reuters
·
Jan 15

AvePoint Is Maintained at Neutral by Citigroup

Dow Jones
·
Jan 14

U.S. RESEARCH ROUNDUP-Cencora, Kennametal, Regeneron Pharmaceuticals

Reuters
·
Jan 13

AvePoint Initiated at Overweight by Stephens & Co.

Dow Jones
·
Dec 30, 2025

Stephens Initiates AvePoint at Overweight With $18 Price Target

MT Newswires Live
·
Dec 30, 2025

BUZZ-Okta rises after Jefferies upgrades to 'buy'

Reuters
·
Dec 16, 2025

AvePoint Executive Chairman Xunkai Gong Reports Sale of Common Shares

Reuters
·
Dec 11, 2025

AvePoint (AVPT) Is Up 6.6% After Analyst Upgrades and Top Zacks Rank Signal Renewed Optimism

Simply Wall St.
·
Dec 10, 2025